These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19829304)

  • 1. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission.
    Nikolic DS; Piguet V
    J Invest Dermatol; 2010 Feb; 130(2):352-61. PubMed ID: 19829304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. siRNA-based topical microbicides targeting sexually transmitted infections.
    Katakowski JA; Palliser D
    Curr Opin Mol Ther; 2010 Apr; 12(2):192-202. PubMed ID: 20373263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microbicides for preventing sexually transmitted infections: Current status and strategies for preclinical evaluation of new candidates].
    Fernández Romero JA; Gil PI; Ré V; Robbiani M; Paglini G
    Rev Argent Microbiol; 2014; 46(3):256-68. PubMed ID: 25444135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease.
    Garnett GP
    J Infect Dis; 2005 Feb; 191 Suppl 1():S97-106. PubMed ID: 15627236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vertical trasmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI)].
    Casalini C; Signorini L; Beltrame A; Matteelli A; Carosi G
    Minerva Ginecol; 2001 Jun; 53(3):177-92. PubMed ID: 11395690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Studies of Viral Entry: An Overview of Dendrimer-Based Microbicides As Entry Inhibitors Against Both HIV and HSV-2 Overlapped Infections.
    Sepúlveda-Crespo D; Ceña-Díez R; Jiménez JL; Ángeles Muñoz-Fernández M
    Med Res Rev; 2017 Jan; 37(1):149-179. PubMed ID: 27518199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention.
    Thurman AR; Doncel GF
    Int J STD AIDS; 2012 Sep; 23(9):613-9. PubMed ID: 23033511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 2 and heterosexual spread of human immunodeficiency virus infection in developing countries: hypotheses and research priorities.
    Mbopi-Keou FX; Robinson NJ; Mayaud P; Belec L; Brown DW
    Clin Microbiol Infect; 2003 Mar; 9(3):161-71. PubMed ID: 12667248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and concordance of HPV, HIV, and HSV-2 in heterosexual couples in Kigali, Rwanda.
    Veldhuijzen NJ; Dhont N; Vyankandondera J; Gasarabwe A; Busasa R; Crucitti T; van de Wijgert JH
    Sex Transm Dis; 2012 Feb; 39(2):128-35. PubMed ID: 22249302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a multi-epitope protein vaccine against herpes simplex virus, human papillomavirus and Chlamydia trachomatis as the main causes of sexually transmitted diseases.
    Dorosti H; Eskandari S; Zarei M; Nezafat N; Ghasemi Y
    Infect Genet Evol; 2021 Dec; 96():105136. PubMed ID: 34775078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessments of vaginal microbicide candidate safety and efficacy.
    Fernández-Romero JA; Teleshova N; Zydowsky TM; Robbiani M
    Adv Drug Deliv Rev; 2015 Sep; 92():27-38. PubMed ID: 25543007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery in multiple indication (multipurpose) prevention technologies: systems to prevent HIV-1 transmission and unintended pregnancies or HSV-2 transmission.
    Friend DR
    Expert Opin Drug Deliv; 2012 Apr; 9(4):417-27. PubMed ID: 22385316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc acetate/carrageenan gels exhibit potent activity in vivo against high-dose herpes simplex virus 2 vaginal and rectal challenge.
    Fernández-Romero JA; Abraham CJ; Rodriguez A; Kizima L; Jean-Pierre N; Menon R; Begay O; Seidor S; Ford BE; Gil PI; Peters J; Katz D; Robbiani M; Zydowsky TM
    Antimicrob Agents Chemother; 2012 Jan; 56(1):358-68. PubMed ID: 22064530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Exposure to PC-1005 and Cervicovaginal Lavage Fluid from Women Vaginally Administered PC-1005 Inhibits HIV-1 and HSV-2 Infection in Human Cervical Mucosa.
    Villegas G; Calenda G; Zhang S; Mizenina O; Kleinbeck K; Cooney ML; Hoesley CJ; Creasy GW; Friedland B; Fernández-Romero JA; Zydowsky TM; Teleshova N
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5459-66. PubMed ID: 27381393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicides and other topical agents in the prevention of HIV and sexually transmitted infections.
    Nikolic DS; Garcia E; Piguet V
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):77-88. PubMed ID: 17266456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy.
    Ugaonkar SR; Wesenberg A; Wilk J; Seidor S; Mizenina O; Kizima L; Rodriguez A; Zhang S; Levendosky K; Kenney J; Aravantinou M; Derby N; Grasperge B; Gettie A; Blanchard J; Kumar N; Roberts K; Robbiani M; Fernández-Romero JA; Zydowsky TM
    J Control Release; 2015 Sep; 213():57-68. PubMed ID: 26091920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbicides for the prevention of sexually transmitted HIV infection.
    Karim QA; Baxter C
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):13-23. PubMed ID: 23428099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical microbicides for the prevention of genital herpes infection.
    Keller MJ; Tuyama A; Carlucci MJ; Herold BC
    J Antimicrob Chemother; 2005 Apr; 55(4):420-3. PubMed ID: 15743896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides.
    Madan RP; Keller MJ; Herold BC
    Curr Opin Infect Dis; 2006 Feb; 19(1):49-54. PubMed ID: 16374218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.